Holly Slyne1, Natalie Clews1, Sid Beech2, Elizabeth Smilie2. 1. Infection Prevention & Control Team, Northampton General Hospital NHS Trust, Northampton, UK. 2. Quality Improvement Team, Northampton General Hospital NHS Trust, Northampton, Northamptonshire, UK.
Abstract
BACKGROUND: At a medium-sized district general hospital in the heart of England, it was identified that compliance to the administration of topical prophylaxis on three general surgery wards had reduced to 23%, following implementation of an electronic medication prescription record. Therefore, a quality improvement project was commenced to improve this compliance to protect patients from meticillin-resistant Staphylococcus aureus (MRSA) colonisation and associated bacteraemia. AIM: To improve compliance of topical prophylaxis administration on three surgical wards to protect patients from infection. METHOD: Quality improvement plan - do - study - act (PDSA) cycles evaluated the effectiveness of four different strategies from baseline data which was 23% compliant in December 2016. These included teaching and communication strategies, prompts in medical notes, discontinuation of Mupirocin 2% nasal ointment as part of the topical prophylaxis regime and discontinuation of the topical wash lotion from requiring a prescription. RESULTS: The compliance of prophylaxis administration increased consistently throughout from 23% in December 2016 to 92% in March 2018. Consequently, the number of patients that developed a MRSA colonisation on the three wards reduced by 54%, from 13 in the 12 months before the study to six in the 12 months after the study. DISCUSSION: This study led to a change in the Trust MRSA Policy to better protect patients from infection, particularly surgical site infection and MRSA bacteraemia. It suggests that quality improvement methodology has a place in infection prevention practice.
BACKGROUND: At a medium-sized district general hospital in the heart of England, it was identified that compliance to the administration of topical prophylaxis on three general surgery wards had reduced to 23%, following implementation of an electronic medication prescription record. Therefore, a quality improvement project was commenced to improve this compliance to protect patients from meticillin-resistant Staphylococcus aureus (MRSA) colonisation and associated bacteraemia. AIM: To improve compliance of topical prophylaxis administration on three surgical wards to protect patients from infection. METHOD: Quality improvement plan - do - study - act (PDSA) cycles evaluated the effectiveness of four different strategies from baseline data which was 23% compliant in December 2016. These included teaching and communication strategies, prompts in medical notes, discontinuation of Mupirocin 2% nasal ointment as part of the topical prophylaxis regime and discontinuation of the topical wash lotion from requiring a prescription. RESULTS: The compliance of prophylaxis administration increased consistently throughout from 23% in December 2016 to 92% in March 2018. Consequently, the number of patients that developed a MRSA colonisation on the three wards reduced by 54%, from 13 in the 12 months before the study to six in the 12 months after the study. DISCUSSION: This study led to a change in the Trust MRSA Policy to better protect patients from infection, particularly surgical site infection and MRSA bacteraemia. It suggests that quality improvement methodology has a place in infection prevention practice.
Authors: H P Loveday; J A Wilson; R J Pratt; M Golsorkhi; A Tingle; A Bak; J Browne; J Prieto; M Wilcox Journal: J Hosp Infect Date: 2014-01 Impact factor: 3.926
Authors: Yee J Tai; Kate L A Borchard; Todd H Gunson; Harvey R Smith; Carl Vinciullo Journal: Australas J Dermatol Date: 2013-02-21 Impact factor: 2.875
Authors: M D Kalmeijer; H Coertjens; P M van Nieuwland-Bollen; D Bogaers-Hofman; G A J de Baere; A Stuurman; A van Belkum; J A J W Kluytmans Journal: Clin Infect Dis Date: 2002-07-15 Impact factor: 9.079
Authors: Trish M Perl; Joseph J Cullen; Richard P Wenzel; M Bridget Zimmerman; Michael A Pfaller; Deborah Sheppard; Jennifer Twombley; Pamela P French; Loreen A Herwaldt Journal: N Engl J Med Date: 2002-06-13 Impact factor: 91.245
Authors: Michael J Taylor; Chris McNicholas; Chris Nicolay; Ara Darzi; Derek Bell; Julie E Reed Journal: BMJ Qual Saf Date: 2013-09-11 Impact factor: 7.035